Kranke Peter, Eberhart Leopold H
Klinik und Poliklinik für Anästhesiologie des Universitätsklinikums Würzburg.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Apr;44(4):286-94; quiz 295. doi: 10.1055/s-0029-1222437. Epub 2009 Apr 14.
Postoperative nausea and vomiting (PONV) constitutes a major unpleasant symptom in the postoperative period. The prevention of PONV is judged equally important as the prevention of postoperative pain. Therefore, a working PONV-algorithm should be as self-evident as the approach to prevent and treat postoperative pain. None of the currently available pharmacological interventions is able to totally abolish PONV. However, using a multimodal approach with the combination of various antiemetic interventions, a substantial reduction or even elimination of PONV is already feasible. As a rule of thumb, each effective antiemetic intervention will lead to a relative risk reduction of approximately 30 %. Well documented interventions in terms of the aforementioned efficacy are the administration of ondansetron 4 mg, dexamethasone 4 mg, droperidol 1,25mg and dimenhydrinate 62 mg, as well oral Aprepitant. Metoclopramide may play a role for instance in a multimodal approach. Apart from the administration of antiemetics, the avoidance of inhalational anaesthetics by using propofol is associated with a comparable risk reduction. In general, using a risk-dependent approach, e.g. based on a simplified risk score, allows to avoid administering antiemetics to patients at low risk. However, due to the difficulties associated with the implementation of risk-score based algorithms and the inherent weaknesses of clinical risk scores to predict PONV in an individual patient, a general (multimodal) approach seem to be justified as well. Considering the fact that the currently available antiemetics are associated with few side effects, the administration of prophylactic antiemetics should not be associated with a high hurdle in the clinical setting. In case of any doubts regarding the individual risk, it seems justified to expand the (multimodal) prophylaxis rather than to wait until PONV occurs and impairs patient comfort.
术后恶心呕吐(PONV)是术后阶段的一种主要不适症状。预防PONV被认为与预防术后疼痛同样重要。因此,一个有效的PONV算法应如同预防和治疗术后疼痛的方法一样显而易见。目前可用的任何药物干预都无法完全消除PONV。然而,采用多种抗呕吐干预措施相结合的多模式方法,已经可以大幅减少甚至消除PONV。一般来说,每种有效的抗呕吐干预措施都会使相对风险降低约30%。在上述疗效方面有充分记录的干预措施包括给予4毫克昂丹司琼、4毫克地塞米松、1.25毫克氟哌利多和62毫克茶苯海明,以及口服阿瑞匹坦。甲氧氯普胺例如在多模式方法中可能发挥作用。除了使用抗呕吐药物外,使用丙泊酚避免吸入性麻醉剂也可降低类似的风险。一般来说,采用基于风险的方法,例如基于简化的风险评分,可以避免对低风险患者使用抗呕吐药物。然而,由于基于风险评分的算法实施困难以及临床风险评分在预测个体患者PONV方面的固有弱点,采用一般的(多模式)方法似乎也是合理的。考虑到目前可用的抗呕吐药物副作用较少,在临床环境中给予预防性抗呕吐药物不应存在很大障碍。如果对个体风险有任何疑问,扩大(多模式)预防措施似乎是合理的,而不是等到PONV发生并影响患者舒适度。